Combiflam Export Market Intelligence: India's 42 Suppliers Shipping to 21 Countries — TransData Nexus 2026

Q: Who are the top combiflam exporters from India?

The top combiflam exporters from India are: 1. CAPSTONE EXPORT & IMPORT — $5.1K (21.0% market share); 2. VEA IMPEX (I) PRIVATE LIMITED — $2.2K (9.1% market share); 3. SHAURYA INTERNATIONAL — $2.0K (8.2% market share); 4. NAMAN GLOBAL IMPEX PRIVATE LIMITED — $1.6K (6.6% market share); 5. N CHIMANLAL ENTERPRISES — $1.0K (4.2% market share). Together they account for 49.1% of India's total combiflam export value.

Q: What is the total export value of combiflam from India?

The total export value of combiflam from India is $24.3K USD, recorded across 174 shipment transactions from 42 active exporters to 21 destination countries. The average shipment value is $140.

Q: Which countries import combiflam from India?

India exports combiflam to 21 countries worldwide. The top importing countries are: SEYCHELLES (53.3% share, $12.9K), GUINEA (17.3% share, $4.2K), AFGHANISTAN (13.4% share, $3.3K), CAYMAN ISLANDS (4.8% share, $1.2K), PAKISTAN (4.4% share, $1.1K). These five markets account for 93.1% of total export value.

Q: What is the HS code for combiflam exports from India?

The primary HS code for combiflam exports from India is 30049063. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) for tracking and reporting pharmaceutical trade flows.

Q: What is the average price of combiflam exports from India?

The average unit price for combiflam exports from India is $1.68 USD per unit, with prices ranging from $0.02 to $40.87 depending on formulation, packaging, and order volume. The total market is valued at $24.3K across 174 shipments.

Q: Which ports handle combiflam exports from India?

The primary ports for combiflam exports from India are SAHAR AIR CARGO ACC (INBOM4) (17.8% of shipments), CHENNAI AIR (14.4% of shipments), SAHAR AIR (13.2% of shipments), CHENNAI AIR CARGO ACC (INMAA4) (9.2% of shipments), Bombay Air (8.6% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Q: Why is India a leading exporter of combiflam?

India is one of the world's leading exporters of combiflam due to its large base of 42 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports combiflam to 21 countries, demonstrating 11% global market coverage.

Q: What certifications do Indian combiflam exporters need?

Indian combiflam exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

Q: How many buyers import combiflam from India?

There are 68 registered buyers importing combiflam from India, spread across 21 countries. The repeat buyer rate is 48.5%, indicating strong long-term trade relationships and consistent product quality.

Q: What is the market share of the top combiflam supplier from India?

CAPSTONE EXPORT & IMPORT is the leading combiflam exporter from India with a market share of 21.0% and total export value of $5.1K across 14 shipments. The top 5 suppliers together control 49.1% of total export value.

Suresh Sormare

Combiflam

India Pharmaceutical Trade Intelligence

$24.3K42 Suppliers21 CountriesHS 30049063

ExportsIndia → SEYCHELLES53.3%India → GUINEA17.3%

#1 Supplier: CAPSTONE EXPORT

Combiflam Export Analysis | India Pharmaceutical Trade Intelligence | TransData Nexus

How India Exports Combiflam to the World

Between 2022 and 2026, India exported $24.3K worth of combiflam across 174 verified shipments to 21 countries — covering 11% of world markets in the Brand Names & OTC Products segment. The largest destination is SEYCHELLES (53.3%). CAPSTONE EXPORT & IMPORT leads with a 21.0% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published March 2026·Updated March 2026·

Combiflam export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Combiflam export data snapshot — $24.3K · 42 exporters · 21 countriesTransData Nexus · Indian Customs Data

Top Combiflam Exporters from India

42 active exporters · Ranked by export value

View all 42 →

Top Combiflam Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	CAPSTONE EXPORT & IMPORT	$5.1K	14	1	21.0%
2	VEA IMPEX (I) PRIVATE LIMITED

Top Countries Importing Combiflam from India

21 destination markets · Ranked by import value

All 21 countries →

Top Countries Importing Combiflam from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	SEYCHELLES	$12.9K	53.3%
2	GUINEA	$4.2K	17.3%
3	AFGHANISTAN	$3.3K	13.4%
4	CAYMAN ISLANDS	$1.2K	4.8%
5	PAKISTAN	$1.1K	4.4%
6	TAJIKISTAN	$519	2.1%
7	DOMINICA	$396	1.6%
8	UNITED KINGDOM	$215	0.9%
9	UNITED STATES	$131	0.5%
10	SOUTH AFRICA	$110	0.5%

SEYCHELLES is India's largest combiflam export destination, absorbing 53.3% of total exports worth $12.9K. The top 5 importing countries — SEYCHELLES, GUINEA, AFGHANISTAN, CAYMAN ISLANDS, PAKISTAN — together account for 93.1% of India's total combiflam export value. The remaining 16 destination countries collectively receive the other 6.9%, indicating a focused distribution strategy targeting key markets.

Regulatory Landscape — Combiflam

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

As of March 2026, the FDA's Orange Book does not list any approved Abbreviated New Drug Applications (ANDAs) for Combiflam or its generic equivalents. This indicates that no manufacturers have received FDA approval to market this specific combination in the United States. Consequently, Combiflam is not authorized for sale in the U.S. market.

The absence of FDA approval suggests that Indian exporters have not pursued the regulatory pathway required for U.S. market entry, which involves submitting an ANDA demonstrating bioequivalence to a reference listed drug. Additionally, there are no import alerts related to Combiflam or its components from India, indicating no specific FDA concerns regarding this product.

2EU & UK Regulatory Framework

In the European Union, the European Medicines Agency (EMA) oversees the approval of medicinal products. A similar combination of ibuprofen and paracetamol is available in some EU countries; however, specific marketing authorizations for Combiflam are not documented in EMA's centralized records. This suggests that Combiflam may not have sought or obtained centralized approval within the EU.

In the United Kingdom, the Medicines and Healthcare products Regulatory Agency (MHRA) requires a marketing authorization for medicinal products. There is no public record indicating that Combiflam has obtained such authorization in the UK. Compliance with EU Good Manufacturing Practice (GMP) standards is mandatory for products marketed in these regions, ensuring quality and safety.

3WHO Essential Medicines & Global Standards

The World Health Organization (WHO) includes both ibuprofen and paracetamol individually in its Model List of Essential Medicines, recognizing their importance in healthcare. However, the combination of these two active ingredients, as found in Combiflam, is not listed in the current edition. This absence may influence procurement decisions by international health organizations.

Regarding pharmacopoeial standards, both ibuprofen and paracetamol are monographed in major compendia such as the United States Pharmacopeia (USP), British Pharmacopoeia (BP), European Pharmacopoeia (EP), and Indian Pharmacopoeia (IP). Compliance with these standards is essential for ensuring the quality and efficacy of pharmaceutical products.

4India Regulatory Classification

In India, Combiflam is classified under Schedule H of the Drugs and Cosmetics Rules, indicating that it is a prescription-only medication. The National Pharmaceutical Pricing Authority (NPPA) regulates the pricing of essential medicines; however, as of March 2026, there is no specific ceiling price listed for the ibuprofen and paracetamol combination. For exports, the Directorate General of Foreign Trade (DGFT) mandates a No Objection Certificate (NOC) for certain pharmaceutical products, ensuring compliance with export regulations.

5Patent & Exclusivity Status

The combination of ibuprofen and paracetamol is not under patent protection, allowing multiple manufacturers to produce and market generic versions. This lack of exclusivity has led to a competitive market landscape, both domestically and internationally.

6Recent Industry Developments

In December 2025, the NPPA announced a revision of the ceiling prices for several essential medicines, although the ibuprofen and paracetamol combination was not included in this update. In January 2026, the CDSCO issued new guidelines for the export of pharmaceutical products, emphasizing the need for stringent quality checks and compliance with international standards. In February 2026, the WHO updated its Model List of Essential Medicines, maintaining the individual listings for ibuprofen and paracetamol but not including their combination.

These developments underscore the dynamic nature of the pharmaceutical regulatory environment and the importance of continuous monitoring to ensure compliance and market access.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Global Price Benchmark — Combiflam

Retail & reference prices across 9 markets vs. India FOB export price of $1.68/unit

Global Price Benchmark for Combiflam across major pharmaceutical markets
Market	Price (USD/unit)	Currency	Reference
United States	$0.10	USD	According to the FDA Orange Book, ibuprofen and paracetamol combination products are available as generic medications.
United Kingdom	$0.11	GBP	The NHS Drug Tariff lists ibuprofen and paracetamol combination tablets as available for prescription.
Germany	$0.10	EUR	The Federal Institute for Drugs and Medical Devices (BfArM) regulates the pricing of over-the-counter medications, including ibuprofen and paracetamol combinations.
Australia	$0.11

Supply Chain Risk Assessment — Combiflam

API sourcing, concentration risk, storage requirements, and current alerts

MEDIUM RISK

1API Sourcing & Raw Material Dependency

Combiflam, a widely used analgesic and antipyretic, relies on active pharmaceutical ingredients (APIs) such as ibuprofen and paracetamol. India, a major producer of these APIs, often sources key starting materials (KSMs) from China, which controls approximately 70–80% of the global KSM supply. This dependency exposes the supply chain to risks associated with geopolitical tensions and trade disruptions.

Recent events have further highlighted these vulnerabilities. In March 2026, the closure of the Strait of Hormuz disrupted the supply of petrochemical feedstocks essential for API synthesis, leading to production cutbacks and increased costs. This situation underscores the fragility of pharmaceutical supply chains reliant on specific geographic regions for critical raw materials.

2Supplier Concentration & Single-Source Risk

Our proprietary trade data indicates that the top five exporters of Combiflam from India account for 49.1% of total exports, with CAPSTONE EXPORT & IMPORT leading at a 21.0% share. This concentration suggests a moderate risk of supply disruption if any of these key suppliers face operational challenges.

To mitigate such risks, the Indian government has implemented the Production Linked Incentive (PLI) scheme, aiming to boost domestic API production and reduce reliance on imports. However, the effectiveness of this initiative in diversifying the supplier base for Combiflam remains to be fully realized.

Access Complete Combiflam Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 174 transactions across 21 markets.

Request Demo View Pricing

Frequently Asked Questions — Combiflam Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top combiflam exporters from India?

The leading combiflam exporters from India are CAPSTONE EXPORT & IMPORT, VEA IMPEX (I) PRIVATE LIMITED, SHAURYA INTERNATIONAL, and 3 others. CAPSTONE EXPORT & IMPORT leads with 21.0% market share ($5.1K). The top 5 suppliers together control 49.1% of total export value.

What is the total export value of combiflam from India?

The total export value of combiflam from India is $24.3K, recorded across 174 shipments from 42 active exporters to 21 countries. The average shipment value is $140.

Which countries import combiflam from India?

India exports combiflam to 21 countries. The top importing countries are SEYCHELLES (53.3%), GUINEA (17.3%), AFGHANISTAN (13.4%), CAYMAN ISLANDS (4.8%), PAKISTAN (4.4%), which together account for 93.1% of total export value.

What is the HS code for combiflam exports from India?

The primary HS code for combiflam exports from India is 30049063. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Combiflam

Combiflam

How India Exports Combiflam to the World

Top Combiflam Exporters from India

Top Countries Importing Combiflam from India

Quick Facts

Related Brand Names & OTC Products

Related Analysis

Need Details?

Regulatory Landscape — Combiflam

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Global Price Benchmark — Combiflam

Supply Chain Risk Assessment — Combiflam

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

Access Complete Combiflam Trade Intelligence

Frequently Asked Questions — Combiflam Exports from India

Who are the top combiflam exporters from India?

What is the total export value of combiflam from India?

Which countries import combiflam from India?

What is the HS code for combiflam exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

India Cost Advantage

3Geopolitical & Shipping Disruptions

4Risk Mitigation Recommendations

What is the average price of combiflam exports from India?

Which ports handle combiflam exports from India?

Why is India a leading exporter of combiflam?

What certifications do Indian combiflam exporters need?

How many buyers import combiflam from India?

What is the market share of the top combiflam exporter from India?

Analysis Methodology